Alembic Pharmaceuticals Ltd

NSE :APLLTD BSE :533573 Sector : Pharmaceuticals

Buy, Sell or Hold APLLTD? Ask The Analyst

Check Gift Nifty (SGX Nifty) Live Price to predict the market.

BSE

prev close

OPEN PRICE

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

volume

Today's' low / high

52 WK low / high

25 Mar
935.35
(-2.48%)

24 Mar
959.15
(0.69%)

21 Mar
952.60
(14.12%)

20 Mar
834.70
(-0.81%)

19 Mar
841.50
(0.71%)

18 Mar
835.55
(1.65%)

17 Mar
822.00
(-0.65%)

13 Mar
827.35
(2.66%)

12 Mar
805.90
(-0.05%)

11 Mar
806.30
(-2.32%)

10 Mar
825.45
(-2.27%)

07 Mar
844.65
(4.10%)

06 Mar
811.35
(0.92%)

05 Mar
803.95
(1.52%)

04 Mar
791.90
(6.37%)

03 Mar
744.50
(0.11%)

28 Feb
743.65
(-4.18%)

27 Feb
776.10
(-1.98%)

25 Feb
791.80
(-0.42%)

24 Feb
795.10
(-1.03%)

21 Feb
803.40
(-1.34%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish

Medium Term Investors

Neutral

Long Term Investors

Bearish

Moving Averages

5 DMA

Bullish

904.43

10 DMA

Bullish

861.77

20 DMA

Bullish

827.23

50 DMA

Bullish

878.39

100 DMA

Bearish

972.3

200 DMA

Bearish

1030.97

Intraday Support and Resistance
(Based on Pivot Points) undefined |

Updated On Mar 25, 2025 04:00 PM For Next Trading Session

Pivots	Classic	Fibonacci	Camarilla	Woodie	DM
R3	994.05	977.05	945.76	-	-
R2	977.05	962.59	942.29	976.09	-
R1	956.2	953.66	938.82	954.28	966.63
P	939.2	939.2	939.2	938.24	944.41
S1	918.35	924.74	931.88	916.43	928.78
S2	901.35	915.81	928.41	900.39	-
S3	880.5	901.35	924.94	-	-

Key Metrics

EPS

31.49

P/E

29.7

P/B

3.65

Dividend Yield

1.18%

Market Cap

18,386 Cr.

Face Value

2

Book Value

255.98

ROE

13.4%

EBITDA Growth

269.08 Cr.

Debt/Equity

0.13 Shareholding Pattern

	69.61%	Total Promoter Holding

	8.96%	Mutual Fund Holdings

	4.17%	FIIs

	10.16%	Non Institution

	6.7%	Insurance Companies

	0%	Custodians

	0.4%	Other Parties

Shareholding History

Alembic Pharmaceuticals Ltd Quaterly Results

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
INCOME	1633.46	1520.58	1564.15	1678.45	1702.6
PROFIT	180.45	178.21	134.71	143.41	138.42
EPS	9.23	8.48	6.84	7.79	7.01

Alembic Pharmaceuticals Ltd Quaterly Results

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
INCOME	1591.69	1481.77	1478.71	1609.28	1421.55
PROFIT	233.24	201.87	176.19	155.11	85.81
EPS	11.87	10.27	8.96	8.43	4.37

Profit & Loss (Figures in Rs. Crores)

Consolidated
Standalone

Alembic Pharmaceuticals Ltd Profit & Loss

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
INCOME	2133.34	3269.05	3177.12	3179.9	4036.33	4821.28	5674.35	5404.72	5576.71	6399.77
PROFIT	282.92	720.05	403.59	408.91	582.26	861.88	1141.34	518.23	345.93	612.84
EPS	14.28	38.2	21.59	22.33	31.44	42.47	56.72	26.5	17.4	31.33

Alembic Pharmaceuticals Ltd Profit & Loss

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
INCOME	2094.48	3111.78	3036.4	2988.11	3747.11	4443.8	5311.44	5066.7	5079.7	5957.74
PROFIT	286.61	698.71	430.58	418.2	609.06	976.46	1091.34	540.74	346.68	665.49
EPS	14.49	37.07	22.85	22.39	32.42	51.43	55.79	27.65	17.64	33.91

Balance Sheet (Figures in Rs. Crores)

Consolidated
Standalone

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
SOURCES OF FUNDS :
Share Capital	39.31	39.31	39.31	39.31	37.7	37.7	37.7	37.7	37.7	37.7
Reserves Total	4,778.89	4,331.16	5,198.23	5,027.66	3,181.71	2,681.12	2,182.44	1,864.63	1,559.66	846.94
Total Shareholders Funds	4,818.2	4,370.47	5,237.54	5,066.97	3,219.41	2,718.82	2,220.14	1,902.33	1,597.36	884.64
Minority Interest	0	0	0	0	-28.96	-0.79	0.31	0.11	0	0
Secured Loans	100.04	165.07	0	0.02	0.04	34.93	46.53	8.27	113.71	233.5
Unsecured Loans	413.12	556.95	717.11	583.59	1,747.45	1,093.5	661.25	80.24	0	30
Total Debt	513.16	722.02	717.11	583.61	1,747.49	1,128.43	707.78	88.51	113.71	263.5
Other Liabilities	109.51	106.2	95.82	85.52	147.81	52.03	40.76	57.22	41.28	22.21
Total Liabilities	5,440.87	5,198.69	6,050.47	5,736.1	5,085.75	3,898.49	2,968.99	2,048.17	1,752.35	1,170.35
APPLICATION OF FUNDS :
Gross Block	3,875.19	3,467.5	2,840.34	2,545.41	2,132.42	1,522.57	1,242.44	950.09	1,093.63	861.06
Less: Accumulated Depreciation	1,328.48	1,069.05	1,042.49	756.99	580.58	364.12	249.06	150.69	385.54	314.19
Net Block	2,546.71	2,398.45	1,797.85	1,788.42	1,551.84	1,158.45	993.38	799.4	708.09	546.87
Capital Work in Progress	524.36	601.28	2,304.23	2,182.53	1,846.18	1,551.23	1,010.15	396.28	92.52	83.14
Investments	93.02	96.33	118.4	236.28	17.62	48.76	41.64	49.88	86.73	2.26
Inventories	1,643.54	1,475.27	1,609.7	1,486.15	1,187.53	967.26	733.93	632.75	569.79	382.77
Sundry Debtors	1,024.84	1,046.4	807.13	348.58	864.75	488.92	526.34	338.82	350.48	361.17
Cash and Bank Balance	126.57	82.27	69.43	105.84	80.75	205.62	89.92	159.6	450.83	26.83
Loans and Advances	283.61	306.08	374.53	524.48	329.72	295.96	474.55	241.29	140.17	119.97
Total Current Assets	3,078.56	2,910.02	2,860.79	2,465.05	2,462.75	1,957.76	1,824.74	1,372.46	1,511.27	890.74
Current Liabilities	939.46	914.08	1,007.92	914.53	852.92	824.56	902.2	582.01	617.45	344.51
Provisions	65.25	70.06	63.64	54.14	38.19	36	34.4	22.15	16.03	94.88
Total Current Liabilities & Provisions	1,004.71	984.14	1,071.56	968.67	891.11	860.56	936.6	604.16	633.48	439.39
Net Current Assets	2,073.85	1,925.88	1,789.23	1,496.38	1,571.64	1,097.2	888.14	768.3	877.79	451.34
Deferred Tax Assets	300.92	206.15	203.57	184.71	148.06	122.12	83.04	55.3	23.81	16.25
Deferred Tax Liability	131.28	83.14	197.69	188.92	160.25	140.86	118.5	92.23	66.55	47.68
Net Deferred Tax	169.64	123.01	5.88	-4.21	-12.19	-18.74	-35.46	-36.93	-42.74	-31.43
Other Assets	33.29	53.74	34.88	36.7	110.66	61.59	71.14	71.24	29.96	118.15
Total Assets	5,440.87	5,198.69	6,050.47	5,736.1	5,085.75	3,898.49	2,968.99	2,048.17	1,752.35	1,170.33
Contingent Liabilities	54.61	109.23	62.87	100.46	117.8	103.98	94.04	82.07	108.61	104.84

	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
SOURCES OF FUNDS :
Share Capital	39.31	39.31	39.31	39.31	37.7	37.7	37.7	37.7	37.7	37.7
Reserves Total	4,869.6	4,374.99	5,251.03	5,062.5	3,308.31	2,674.71	2,156.94	1,829.62	1,493.04	795.86
Total Shareholders Funds	4,908.91	4,414.3	5,290.34	5,101.81	3,346.01	2,712.41	2,194.64	1,867.32	1,530.74	833.56
Secured Loans	100.04	165.07	0	0.02	0.04	34.93	46.53	8.28	0	163.61
Unsecured Loans	391.95	544.86	706.12	583.59	1,686.99	1,024.35	575	0	0	30
Total Debt	491.99	709.93	706.12	583.61	1,687.03	1,059.28	621.53	8.28	0	193.61
Other Liabilities	109.51	106.2	95.82	85.52	146.51	51.33	40.43	57.22	41.28	22.21
Total Liabilities	5,510.41	5,230.43	6,092.28	5,770.94	5,179.55	3,823.02	2,856.6	1,932.82	1,572.02	1,049.38
APPLICATION OF FUNDS :
Gross Block	3,859.15	3,441.27	2,733.1	2,452.31	1,761.67	1,435.06	1,162.61	948.64	1,082.44	802.85
Less : Accumulated Depreciation	1,323.49	1,063.82	962	678.49	485.21	349.62	244.31	149.63	385.19	314.17
Net Block	2,535.66	2,377.45	1,771.1	1,773.82	1,276.46	1,085.44	918.3	799.01	697.25	488.68
Capital Work in Progress	524.36	601.28	2,304.23	2,182.53	1,569.98	1,106.89	740.64	347.75	92.34	83.14
Investments	226.68	229.27	219.36	343.09	833.25	506.39	298.89	103.04	37.46	33.33
Inventories	1,353.07	1,275.13	1,396.83	1,341.96	1,073.18	891.41	669.93	574.62	533.72	382.48
Sundry Debtors	1,340.12	1,201.2	988.33	421.86	784.11	539.78	621.66	467.41	371.5	337.94
Cash and Bank Balance	26.49	28.46	21.9	61.44	37.13	150.8	15.63	7.21	284.81	4.41
Loans and Advances	268.87	275.43	337.41	482.37	256.95	254.04	368.47	173.56	134.69	116.15
Total Current Assets	2,988.55	2,780.22	2,744.47	2,307.63	2,151.37	1,836.03	1,675.69	1,222.8	1,324.72	840.98
Current Liabilities	823.25	830.03	871.72	772.7	615.29	648.4	742.25	510.46	551.08	335.75
Provisions	64.88	69.96	63.64	53.71	38.17	32.37	34.4	22.07	16	94.6
Total Current Liabilities & Provisions	888.13	899.99	935.36	826.41	653.46	680.77	776.65	532.53	567.08	430.35
Net Current Assets	2,100.42	1,880.23	1,809.11	1,481.22	1,497.91	1,155.26	899.04	690.27	757.64	410.63
Deferred Tax Assets	210.11	161.3	151.29	142.8	114.49	95.59	73.86	48.45	23.7	16.25
Deferred Tax Liability	131.28	83.14	197.69	188.92	160.25	140.86	118.5	92.23	66.33	47.68
Net Deferred Tax	78.83	78.16	-46.4	-46.12	-45.76	-45.27	-44.64	-43.78	-42.63	-31.43
Other Assets	44.46	64.04	34.88	36.4	47.71	14.31	44.37	36.53	29.96	65.03
Total Assets	5,510.41	5,230.43	6,092.28	5,770.94	5,179.55	3,823.02	2,856.6	1,932.82	1,572.02	1,049.38
Contingent Liabilities	65.03	117.45	62.87	100.46	190.28	259.35	196.18	167.59	223.24	104.84

Cash Flow (Figures in Rs. Crores)

Consolidated
Standalone

Cash from Operating Activity 803.2

Net Profit before Tax and Extr...	631.83
Depreciation	272.67
Interest (Net)	54.1
Dividend Received	1.64
Prov. and W/O (Net)	5.37
P/L in Forex	-40.16
Others	-0.01
Total Adjustments (PBT and Ext...	286.86
Operating Profit before Workin...	918.69
Trade and 0ther Receivables	39.05
Inventories	-168.28
Trade Payables	56.04
Total Adjustments (OP before W...	-95.64
Cash Generated from/(used in) ...	823.05
Direct Taxes Paid	-19.85
Total Adjustments(Cash Generat...	-19.85
Cash Flow before Extraordinary...	803.2
Net Cash from Operating Activi...	803.2

Cash from Investing Activity -320.61

Purchased of Fixed Assets	-327.47
Sale of Fixed Assets	11.56
Purchase of Investments	-8.33
Interest Received	1.99
Net Cash used in Investing Act...	-320.61

Cash from Financing Activity -437.86

Of the Short Term Borrowings	-205.41
Of Financial Liabilities	-25.82
Dividend Paid	-157.25
Interest Paid	-49.37
Net Cash used in Financing Act...	-437.86

Cash from Operating Activity 772.77

Net Profit before Tax and Extr...	704.23
Depreciation	271.14
Interest (Net)	51.67
Dividend Received	1.64
P/L on Sales of Assets	0.58
Prov. and W/O (Net)	5.37
P/L in Forex	-40.15
Others	-0.01
Total Adjustments (PBT and Ext...	284.21
Operating Profit before Workin...	988.44
Trade and 0ther Receivables	-127.21
Inventories	-77.94
Trade Payables	24.31
Total Adjustments (OP before W...	-205.64
Cash Generated from/(used in) ...	782.8
Direct Taxes Paid	-10.03
Total Adjustments(Cash Generat...	-10.03
Cash Flow before Extraordinary...	772.77
Net Cash from Operating Activi...	772.77

Cash from Investing Activity -329.02

Purchased of Fixed Assets	-324.52
Sale of Fixed Assets	0.19
Interest Received	1.99
Invest.In Subsidiaires	-8.32
Net Cash used in Investing Act...	-329.02

Cash from Financing Activity -445.29

Of the Short Term Borrowings	-215.04
Of Financial Liabilities	-24.25
Dividend Paid	-157.25
Interest Paid	-48.74
Net Cash used in Financing Act...	-445.29

Company Details

Registered Office
Address	Alembic Road,
City	Vadodara
State	Gujarat
Pin Code	390003
Tel. No.	91-0265-2280550
Fax. No.	91-0265-2282506
Email	apl.investors@alembic.co.in
Internet	http://www.alembicpharmaceuticals.com/

Registrars
Address	Alembic Road
City	Vadodara
State	Gujarat
Pin Code	390003
Tel. No.	91-0265-2280550
Fax. No.	91-0265-2282506
Email	apl.investors@alembic.co.in
Internet	http://www.alembicpharmaceuticals.com/

Management
Name	Designation
Chirayu R Amin	Chairman & CEO
Rajkumar Baheti	Director (Finance) & CFO
Pranav Amin	Managing Director
Shaunak Amin	Managing Director
Archana Hingorani	Independent Director
Ashok Barat	Independent Director
Manisha Saraf	Company Sec. & Compli. Officer
Jai S Diwanji	Independent Director
Manish Kejriwal	Independent Director
Geeta Goradia	Independent Director

MARKET TODAY

PRODUCTS

SUPPORT

LEGAL & PRIVACY

MAGAZINES

Stocks: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Data is a real-time snapshot *Data is delayed by at least 15 minutes. StockFact, Market Action Data and Analysis. Data Provider CMOTS Infotech.

Disclaimer : There is no guarantee of profits or no exceptions from losses. The investment advice provided is solely the personal views of the research team. Equitypandit will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Therefore, Equitypandit doesn't bear any responsibility for any trading losses you might incur as a result of using this data.

Alembic Pharmaceuticals Ltd

Buy, Sell or Hold APLLTD? Ask The Analyst

BSE

NSE

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish

Medium Term Investors

Neutral

Long Term Investors

Bearish

Moving Averages

5 DMA

Bullish

10 DMA

Bullish

20 DMA

Bullish

50 DMA

Bullish

100 DMA

Bearish

200 DMA

Bearish

Intraday Support and Resistance (Based on Pivot Points) undefined |

Key Metrics

EPS

31.49

P/E

29.7

P/B

3.65

Dividend Yield

1.18%

Market Cap

18,386 Cr.

Face Value

2

Book Value

255.98

ROE

13.4%

EBITDA Growth

269.08 Cr.

Debt/Equity

0.13

Shareholding Pattern

Shareholding History

Quarterly Result (Figures in Rs. Crores)

Alembic Pharmaceuticals Ltd Quaterly Results

Alembic Pharmaceuticals Ltd Quaterly Results

Profit & Loss (Figures in Rs. Crores)

Alembic Pharmaceuticals Ltd Profit & Loss

Alembic Pharmaceuticals Ltd Profit & Loss

Balance Sheet (Figures in Rs. Crores)

Cash Flow (Figures in Rs. Crores)

Company Details

Registered Office

Registrars

Management

MARKET TODAY

PRODUCTS

SUPPORT

LEGAL & PRIVACY

MAGAZINES

Intraday Support and Resistance
(Based on Pivot Points) undefined |